← causal

Alzheimer's

0 causal edges 12 causal effects 12 hypotheses 0 open gaps 8 papers

Causal-edge map (sample)

Explore in Knowledge Graph →
protein:Amyloid-Beta (Aβpathway:beta_amyloidvariant:APOE4 mutation

Inner ring = highest depth_score (out-edges − in-edges). Outer ring = next-most-upstream. Edge thickness = claimed confidence.

Top causal effects

Quantitative effect-size rows from substrate_causal_effects (Q-CAUSAL Phase 1). Sorted by |effect_size| desc.

  1. pathway beta_amyloid → disease alzheimer_disease — p n/a LLM_inferred
  2. disease Alzheimer's_disease → process synaptic_loss — p n/a LLM_inferred
  3. cell Netrin-1-Engineered Endothelial Cell Exosomes → pathway Focal Adhesion — p n/a LLM_inferred
  4. drug CXCR3 blockade → mechanism white matter preservation — p n/a LLM_inferred
  5. pathway Complement Cascade → disease Neuromyelitis Optica — p n/a LLM_inferred
  6. mechanism noradrenaline depletion → mechanism synaptic deficits — p n/a LLM_inferred
  7. mechanism oligodendrocyte sulfatide deficiency → disease AD-like neuroinflammation — p n/a LLM_inferred
  8. drug NAD+ supplementation → mechanism mitophagy enhancement — p n/a LLM_inferred
  9. protein Amyloid-Beta (Aβ) → disease Alzheimer'S Disease — p n/a LLM_inferred
  10. hypothesis h-7ed5dae4 → disease AD — p n/a LLM_inferred

Upstream-target candidates

Ranked by depth_score = out-edges − in-edges. High score = strong upstream signal.

  1. protein:Amyloid-Beta (Aβ) +1 0 mentions
  2. pathway:beta_amyloid +1 0 mentions
  3. variant:APOE4 mutation +1 0 mentions

Leading hypotheses

  1. Alpha-theta entrainment therapy to enhance default mode network coherence
  2. Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymphatic enhancement and amyloid clearance from PV interneurons in Alzheimer's disease
  3. ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matter Degeneration in Alzheimer's Disease
  4. 40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Selectively Eliminate Disease-Associated Microglia
  5. ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes Underlies White Matter Degeneration in Alzheimer's Disease
  6. TREM2-APOE4 Co-targeting — Simultaneous Correction of Lipid Sensing and Clearance Deficits
  7. GFAP-Positive Reactive Astrocyte Subtype Delineation
  8. APOE Isoform Expression Across Glial Subtypes
  9. SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK1/Parkin Mitophagy Dysfunction
  10. Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in Amyloid Phase, Antagonist in Tau Phase
  11. TREM2-DAP12 Signalosome Enhancement — Boosting PI3K-AKT-mTOR Axis for Microglial Metabolic Fitness
  12. Soluble TREM2 (sTREM2) as Therapeutic Mimic — Decoupling Phagocytosis from Inflammation